Skip to main content

How does Xolair work?

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 23, 2024.

Official answer

by Drugs.com
  • Xolair works by preventing IgE from binding to IgE receptors on mast cells and basophils.
  • This prevents mast cells and basophils from releasing histamine and heparin.
  • Histamine narrows smooth muscle in the airways making it harder to breathe and also causes tissue swelling, itchy skin, hives, and other allergic-type symptoms.
  • Heparin makes it harder for blood to clot.

Xolair (omalizumab) is an antibody that may be used to treat allergic asthma that is moderate-to-severe, persistent, and not adequately controlled by inhaled corticosteroids, in adults and children aged 6 and over who have had a positive skin test to an allergen or who react to an allergen that is present in their environment year-round.

Xolair is also approved for:

  • Urticaria (hives) in adults and children aged 12 and older who have already tried antihistamines without success
  • Nasal polyps in adults aged 18 years and older
  • And to reduce the risk of allergic reactions (including anaphylaxis) in adults and children aged 1 year and older with Ig-E-mediated food allergies.

How does Xolair work?

Xolair works by inhibiting the binding of IgE to IgE receptors on mast cells and basophils. Mast cells and basophils are specific cells of the immune system that contain histamine and heparin. As soon as IgE binds to an IgE receptor it causes the release of histamine and heparin from the cell.

Histamine is a chemical that has many inflammatory effects in the body. It contracts the smooth muscle tissue in the lungs, uterus, and stomach; dilates blood vessels causing an increase in permeability and a lowering of blood pressure; stimulates the secretion of gastric acid in the stomach; and speeds up the heart rate. Histamine also causes symptoms such as a runny nose, watery eyes, tissue swelling, itchy skin, and hives.

Because histamine contracts the breathing tubes it can cause wheezing or make it harder to breathe. Histamine is also one of the main chemicals involved in anaphylaxis, a severe and often fatal allergic response to a previously encountered allergen.

Heparin is an anticoagulant that slows the formation of blood clots.

By inhibiting the binding of IgE to the IgE receptor, Xolair prevents the release of histamine and heparin and also reduces the number of IgE receptors on basophils.

IgE levels are increased in people with allergic asthma when they inhale allergens such as pet dander or dust mites which is why Xolair is effective at treating allergic asthma. Xolair will not treat an acute asthma attack or status asthmaticus.

93% of people with moderate-to-severe chronic urticaria have increased total IgE levels.

IgE levels are also increased in people with Ig-E-mediated food allergies when they come into contact with a food allergen.

Related questions

References

Read next

How long before Xolair starts working?

Free serum IgE levels are decreased within an hour of Xolair administration. However it may take several months for the full effects of Xolair to be seen, although some symptom improvement may be noted after a few weeks. Significant improvements were noted after 4 months in those with allergic asthma, after 3 months in those with chronic urticaria, and after 16 to 20 weeks in those with Ig-E-mediated food allergies. Continue reading

Does Xolair cause hair loss?

Hair loss (alopecia), has been reported in Xolair clinical studies in at least 2% of people with chronic hives. Hair loss has also been noted in several case reports with Xolair. The hair loss effect appears to be transient, lasting from 3 to 4 months. Due to limited data, the exact cause of hair loss or how often it occurs is not known. Continue reading

Does Xolair cause cancer?

Xolair is associated with a slightly higher risk of cancer, but cancer specialists have determined that this does not mean that Xolair causes cancer. Research has shown that cancer occurred in 20 out of 4127 trial participants (0.5% of Xolair-treated study volunteers) and 5 out of 2236 (0.2%) of people who were assigned an inactive treatment. Continue reading

Related medical questions

Drug information

Related support groups